CIO Leadership Series: Kim Pemble, SynergyHealth ( matches the order. Nurses also can ...)

(Date:7/2/2008)... develops new therapies based on cells manufacture.../S provide funding round, SALT LAKE CITY and HAMB..., a biotechnology company at the forefront of inno...idney injury, today announced the closing of a,$14...ife Sciences with Novo,A/S joining the syndicate.,...

(Date:7/2/2008).../- Aureus Pharma, a leading provider ...scovery in the life science,industry, announced to...l,be held in Paris on October 23rd and 24th., Thi...inaugural event,which was attended by many of Aure... Europe and North America. The symposium included ...

(Date:7/2/2008)...ance Commercialization of Expanded Portfolio of Va...ANCOUVER, British Columbia, July 2 /-...es Corp. (TSXV: MEV), a company developing and,mar...y announced its name,change and the expansion of i... acquisition of two vascular product development c...

(Date:7/2/2008)...ts to potential of pre-treatment R2 levels as a po...tivity -, TORONTO, July 2 /PRNewswire-FirstCall/ ...Lorus" or the "Corporation"), a biopharmaceutical ...nt of pharmaceutical products and,technologies for...tion by,an Ohio State University (OSU) clinical te...

Breaking Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2 AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3 Aureus Pharma Announces Date of 2008 Annual User Symposium 2 Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2 Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3 Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4 Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2 Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3 Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4 Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5

[0] AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury [0] Aureus Pharma Announces Date of 2008 Annual User Symposium [0] Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing [0] Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

...en the University of Wisconsin-Madison and the Pau...ered a new solution for building nanoelectronics. ...ith because of the complex patterns involved and t...o the scale of individual molecules. , ,Current me... as small as 50 nanometers, a tiny fraction of the...

... and the Wisconsin Technology Council have release... the new economy and the difficulties that still n...tate,s future workforce. , ,Wisconsin Technology ... states such as New Hampshire and Massachusetts ha...rs while Wisconsin has held steady and even gained...

...dison-based rich media systems provider, made two ... 2005, the largest tradeshow and conference in the... is partnering with Vaddio, an automated camera sy...ed and integrated audiovisual presentation system,...es in its line of rich media recorders. , ,In its ...

...umn, we explored the world pharmaceutical market, ...rug blockbusters, super blockbusters and mega bloc...s is on the rise as key Big Pharma companies incre...ive sales forces and globalized pharmaceutical adv...o Big Pharma and a few select other companies. , ,...

Other Biology Technology:Report: Wisconsin still lags in college degrees held by workforce, leads elsewhere 2 Report: Wisconsin still lags in college degrees held by workforce, leads elsewhere 3 Top 20 big pharmas represent majority of world pharma market 2 Top 20 big pharmas represent majority of world pharma market 3

UW-Madison tries new techniques for nanotech Report: Wisconsin still lags in college degrees held by workforce, leads elsewhere Sonic Foundry releases new product line, announces partner at InfoComm Top 20 big pharmas represent majority of world pharma market

(Date:7/3/2008)...stors of such marine creatures as clams, sand doll...ng 144 million years ago with no clear trend after...rchers. This contradicts previous work showing dra...d may shed light on future diversity., "Some of ...t is happening today from global warming," says Jo...

(Date:7/3/2008)..., 2008 -- Sirtris, a GlaxoSmithKline company focus...ugs to treat diseases of aging such as Type 2 Diab...ted in today,s online edition of Cell Metabolism ...e with resveratrol showed an overall health improv... in cataracts and cardiovascular dysfunction, and ...

(Date:7/3/2008)...hris Smit has concluded that small mammals, such a...opment of natural diversity. Smit researched how s...seems that prickly shrubs are important in protect...ing. Smit has also demonstrated that natural distu...ery important for the diversity of natural areas. ...

(Date:7/2/2008)...h team has published the first clear example of ho...diseases that are normally tolerated singly may co... , In a report issued June 25 by PLoS ONE, an ... examined outbreaks of canine distemper virus (CDV... mortality in Serengeti lions. CDV cycles periodic...

[2] Ancient marine invertebrate diversity less explosive than thought [2] Long-term study of middle-aged mice shows [0] Tasty meal out of reach [0] Instances of mass die-offs in wild lions precipitated by extreme climate change

...cEwen Centre for Regenerative Medicine at Toronto ...s signal that mobilizes specific heart repair cell...a heart attack. , While it has long been known tha...dead tissue after a heart attack, what has not bee... of bone marrow adult stem cells in repairing a da...

...s from Wageningen University report in this month,...fied a unique genetic fingerprint in the pathogen ...e pathogen possess multiple copies of a specific g...y. Certain potato plants do not recognize strains...aking them susceptible to infection. This is the ...

...d to a rare disease plays a critical role in the b...eak down, new evidence reported in the May Cell Me...nism underlying healthy fat metabolism and explain...anarin-Dorfman Syndrome (CDS), who carry a mutant ...ildup of fat in tissues throughout their bodies. ,...

Other Biology News:A surprise about our body clock 2 A surprise about our body clock 3 Healing the heart with bone marrow cells 2 Healing the heart with bone marrow cells 3 Potato blight pathogenicity explained by genome plasticity 2 Potato blight pathogenicity explained by genome plasticity 3 Gene linked to rare disease activates fat breakdown 2

A surprise about our body clock Healing the heart with bone marrow cells Potato blight pathogenicity explained by genome plasticity Gene linked to rare disease activates fat breakdown

...t time, you can identify and characterize high-val...tly without interferences. The Agilent Multiple Af...d, multiple high-abundant proteins from human seru...ice. With this revolutionary system, you can: Re...

...olor RNA Spike-In Kit contains in vitro synthesize...neal only to complementary control probes on Agile...dization. The spike-ins serve as a positive microa...TE: This kit is a required component of the Agilen...

...e one mouse-click image analysis software for micr...is the solution for high quality and high throughp...ith VigeneTechs robust algorithms, actual spot bou...ckground correction and dust removal, enhancing th...

...eomic Imaging System, Professional Package Superi...Dynamic Range: The ProXPRESS 2D Proteomic Imaging ... both proteomic and general life science research ...lexibility, enabling the use of all dyes in the UV...

Biology Products:

Multiple Affinity Removal System from Agilent Technologies Two-Color RNA Spike-in Kit , from Agilent Technologies MicroVigene from VigeneTech, Inc.ProXPRESS 2D Proteomic Imaging System, Professional Package from PerkinElmer

( matches the order. Nurses also can ...)CIO Leadership Series: Kim Pemble, SynergyHealth